Contineum Therapeutics (CTNM) FCF Margin (2023)
Contineum Therapeutics' FCF Margin history spans 1 years, with the latest figure at 81.29% for Q2 2023.
- Quarterly FCF Margin changed N/A to 81.29% in Q2 2023 from the year-ago period, while the trailing twelve-month figure was 65.54% through Jun 2024, changed N/A year-over-year, with the annual reading at 38.64% for FY2023, N/A changed from the prior year.
- FCF Margin came in at 81.29% for Q2 2023.
- In the past five years, FCF Margin ranged from a high of 81.29% in Q2 2023 to a low of 81.29% in Q2 2023.